Literature DB >> 22228317

Stopping breastfeeding to prevent vertical transmission of HTLV-1 in resource-poor settings: beneficial or harmful?

Carla van Tienen, Marianne Jakobsen, Maarten Schim van der Loeff.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22228317      PMCID: PMC3374111          DOI: 10.1007/s00404-011-2211-4

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


× No keyword cloud information.
In a recent issue of this journal Mylonas et al. [1] reviewed human T-lymphotropic virus type 1 (HTLV-1) infection and its implications in gynecology and obstetrics. Although HTLV-1 is rare in many populations, it occurs worldwide and is associated with a substantial disease burden and a high risk of vertical transmission. The authors provide recommendations for prevention of sexual and vertical transmission of HTLV-1. One of the recommendations is the following: ‘If stopping breastfeeding is not possible, for example due to socio-economical circumstances, short-term breastfeeding for 3 to a maximum of 6 months should be advocated’. The recommendation in the review is based on two studies from Japan showing reductions of vertical transmission by limiting or avoiding breastfeeding. To our knowledge, no international guidelines exist (e.g. from the WHO or CDC) on breastfeeding and HTLV-1 prevention in resource-poor, developing countries. Therefore, it is important to carefully take into account the risks versus the benefits of advocating short-term breastfeeding in developing countries. Various studies have shown that prolonged breastfeeding is associated with an increased risk of HTLV-1 transmission and avoiding breastfeeding can lead to a dramatic reduction in transmission [2]. A high maternal proviral load in combination with waning antibodies in the child leads to an increased risk of HTLV-1 transmission, especially after 6–12 months after birth [3]. However, the key question is whether the benefits of avoiding HTLV-1 infection outweigh the risks of not breastfeeding. As the review points out, HTLV-1 causes adult T-cell leukemia (ATL) or tropical spastic paraparesis (TSP) in about 5% of infected individuals and is associated with a number of infections and inflammations. On the other hand, the risks of early weaning are substantial. The promotion of breastfeeding for 6–11 months has been estimated to be the most effective strategy to prevent child mortality in resource-limited settings and the WHO recommends at least 6 months of exclusive breastfeeding [4]. Our work in Guinea-Bissau, one of the poorest countries in Sub Saharan Africa with a high prevalence of HTLV-1 (5%) [5, 6], has shown that early weaning (before 12 months) is associated with increased mortality and increased risk of diarrheal diseases among children [7, 8]. For example, the mortality among weaned children was sixfold higher compared to breastfed children during the civil war in Guinea-Bissau in 1996–1997 [7]. In many Sub Saharan countries, vertical transmission of HIV is of major concern. In an editorial from 2010, Humphrey points out the increasing amount of data supporting the fact that in Sub Saharan Africa the risks of early weaning do not outweigh the risks of a possible HIV infection [9]. The 2010 UNAIDS guidelines advice at least 6 months of exclusive breastfeeding and advice to continue breastfeeding after this time if replacement feeding is not feasible, even when anti-retroviral (ARV) drugs are not available (if available, ARVs are recommended for mother and child to reduce the risk of transmission) [10]. Thus, for an infection that has much larger health implications than HTLV-1, breastfeeding longer than 6 months is recommended in certain settings where replacement feeding is not feasible. HTLV-1 infected pregnant women from a poor socio-economic background in a developed country merit extra attention and the advice about not breastfeeding should be tailored to the exact circumstances of the woman. However, it is very likely that these women will have access to good replacement feeding and therefore it seems rational to advise them similarly as women from higher socio-economic status, i.e., to refrain from breastfeeding altogether. In conclusion, in resource-poor settings, like Guinea-Bissau, the immediate health risks of the advocated weaning at 3–6 months are likely to be bigger than the risks of HTLV-1 related morbidity and mortality. This is likely to vary by country and will strongly depend on the socio-economic circumstances and current breastfeeding practices in the country. The available data so far do not support early weaning to prevent vertical transmission of HTLV-1 in resource-limited settings.
  8 in total

1.  The risks of not breastfeeding.

Authors:  Jean H Humphrey
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

Review 2.  HTLV infection and its implication in gynaecology and obstetrics.

Authors:  Ioannis Mylonas; Ansgar Brüning; Franz Kainer; Klaus Friese
Journal:  Arch Gynecol Obstet       Date:  2010-06-22       Impact factor: 2.344

3.  Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica.

Authors:  Michie Hisada; Elizabeth M Maloney; Takashi Sawada; Wendell J Miley; Paulette Palmer; Barrie Hanchard; James J Goedert; Angela Manns
Journal:  Clin Infect Dis       Date:  2002-05-23       Impact factor: 9.079

4.  HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

Authors:  Carla van Tienen; Maarten F Schim van der Loeff; Ingrid Peterson; Matthew Cotten; Birgitta Holmgren; Sören Andersson; Tim Vincent; Ramu Sarge-Njie; Sarah Rowland-Jones; Assan Jaye; Peter Aaby; Hilton Whittle
Journal:  Retrovirology       Date:  2010-06-04       Impact factor: 4.602

5.  Termination of breastfeeding after 12 months of age due to a new pregnancy and other causes is associated with increased mortality in Guinea-Bissau.

Authors:  M S Jakobsen; M Sodemann; K Mølbak; I J Alvarenga; J Nielsen; P Aaby
Journal:  Int J Epidemiol       Date:  2003-02       Impact factor: 7.196

6.  A decrease in mother-to-child transmission of human T lymphotropic virus type I (HTLV-I) in Okinawa, Japan.

Authors:  Kenichiro Kashiwagi; Norihiro Furusyo; Hisashi Nakashima; Norihiko Kubo; Naoko Kinukawa; Seizaburo Kashiwagi; Jun Hayashi
Journal:  Am J Trop Med Hyg       Date:  2004-02       Impact factor: 2.345

7.  Prolonged breast feeding, diarrhoeal disease, and survival of children in Guinea-Bissau.

Authors:  K Mølbak; A Gottschau; P Aaby; N Højlyng; L Ingholt; A P da Silva
Journal:  BMJ       Date:  1994-05-28

8.  Breastfeeding status as a predictor of mortality among refugee children in an emergency situation in Guinea-Bissau.

Authors:  Marianne Jakobsen; Morten Sodemann; Gunnar Nylén; Carlitos Balé; Jens Nielsen; Ida Lisse; Peter Aaby
Journal:  Trop Med Int Health       Date:  2003-11       Impact factor: 2.622

  8 in total
  6 in total

1.  A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population.

Authors:  Fiona Fowler; Lloyd Einsiedel
Journal:  Front Med (Lausanne)       Date:  2022-04-29

Review 2.  Human T cell leukemia virus type 1 and Zika virus: tale of two reemerging viruses with neuropathological sequelae of public health concern.

Authors:  DeGaulle I Chigbu; Pooja Jain; Brenndan L Crumley; Dip Patel; Zafar K Khan
Journal:  J Neurovirol       Date:  2019-01-28       Impact factor: 3.739

3.  Estimation of HTLV-1 vertical transmission cases in Brazil per annum.

Authors:  Carolina Rosadas; Bassit Malik; Graham P Taylor; Marzia Puccioni-Sohler
Journal:  PLoS Negl Trop Dis       Date:  2018-11-12

4.  HTLV-1 in pregnant women from the Southern Bahia, Brazil: a neglected condition despite the high prevalence.

Authors:  Marco Antônio Gomes Mello; Aline Ferreira da Conceição; Sandra Mara Bispo Sousa; Luiz Carlos Alcântara; Lauro Juliano Marin; Mônica Regina da Silva Raiol; Ney Boa-Sorte; Lucas Pereira Souza Santos; Maria da Conceição Chagas de Almeida; Tâmara Coutinho Galvão; Raquel Gois Bastos; Noilson Lázaro; Bernardo Galvão-Castro; Sandra Rocha Gadelha
Journal:  Virol J       Date:  2014-02-13       Impact factor: 4.099

5.  Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors:  Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal:  BMC Public Health       Date:  2016-08-15       Impact factor: 3.295

6.  Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors.

Authors:  Mohammad Reza Hedayati-Moghaddam; Farahnaz Tehranian; Maryam Bayati
Journal:  Viruses       Date:  2015-11-04       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.